Results 181 to 190 of about 82,618 (247)

Therapeutic Potential of Mesenchymal Stem Cells in Pediatric Kidney Disorders: A Comprehensive Review

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Kidney diseases in children present significant health challenges, often leading to complications and reduced quality of life. Mesenchymal stem cell (MSC) therapy shows promise for pediatric kidney disorders. This review evaluates current evidence on MSC applications in pediatric nephrology, focusing on mechanisms, delivery methods,
Mahboube Bahroudi, Mastaneh Moghtaderi
wiley   +1 more source

Prevention of contrast induced nephropathy; a cardiology point of view [PDF]

open access: yesJournal of Nephropharmacology, 2015
Hashemi Mohammad   +2 more
doaj  

Evaluating the effect of crocin on contrast-induced nephropathy in rats. [PDF]

open access: yesAvicenna J Phytomed
Zolfaghari Farajerdi M   +6 more
europepmc   +1 more source

Association Between Neutrophil‐to‐Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta‐Analysis

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Type 2 diabetes mellitus (T2DM) is increasingly seen as a chronic inflammatory state, with the neutrophil‐to‐lymphocyte ratio (NLR) studied as a new biomarker of systemic inflammation. Evidence links NLR to glycemic control, but its consistency and strength vary.
Maryam Mohammadi   +13 more
wiley   +1 more source

DUSP1 Attenuates Renal Injury in Diabetic Nephropathy by Modulating Ferroptosis: Evidence From Animal Experiments

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Objective Emerging evidence suggests that ferroptosis contributes significantly to the progression of diabetic nephropathy (DN). This study aimed to explore the potential association between dual specificity phosphatase 1 (DUSP1) and ferroptosis in a streptozotocin‐induced DN rat model.
Jiarong Liu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy